Rapid Micro Biosystems Inc   (RPID)
Other Ticker:  
Price: $0.9352 $-0.04 -3.984%
Day's High: $0.9645 Week Perf: -2.58 %
Day's Low: $ 0.94 30 Day Perf: -4.91 %
Volume (M): 20 52 Wk High: $ 1.19
Volume (M$): $ 18 52 Wk Avg: $0.99
Open: $0.95 52 Wk Low: $0.74

 Market Capitalization (Millions $) 40
 Shares Outstanding (Millions) 43
 Employees -
 Revenues (TTM) (Millions $) 21
 Net Income (TTM) (Millions $) 29
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 2

Rapid Micro Biosystems Inc
Rapid Micro Biosystems Inc is a life sciences company specializing in the development and provision of automated microbial detection technology. Founded in 2006, the company's mission is to provide innovative solutions for rapid and accurate detection of microbial contamination in the pharmaceutical, biotechnology, and personal care industries. Their core product, Growth Direct, is an automated microbial detection system that significantly reduces the time and effort required for detecting contaminants in various samples. Rapid Micro Biosystems Inc is committed to assisting companies in ensuring product safety and quality by offering efficient and reliable microbial detection solutions.

   Company Address: 1001 Pawtucket Boulevard West Lowell 1854 MA
   Company Phone Number: 349-3200   Stock Exchange / Ticker: NASDAQ RPID


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Rapid Micro Biosystems Inc

Rapid Micro Biosystems Inc Sees Impressive Revenue Growth Amidst Challenging Market Conditions

The stock market has always been a fascinating arena for investors and traders, offering endless opportunities to make profits and grow wealth. And in the third quarter of 2023, Rapid Micro Biosystems Inc has shown some remarkable results, further bolstering its position in the market.
Despite the challenging economic climate and the difficulties faced by competitors in the Laboratory Analytical Instruments sector, Rapid Micro Biosystems Inc has defied the odds and displayed impressive growth. The company's revenue skyrocketed by 29.669% to $6.15 million, compared to $4.74 million in the same period last year. This signifies a significant improvement, as other companies in the sector faced a decline in business during this time.

Rapid Micro Biosystems Inc

Rapid Micro Biosystems Records Tax Charge but Celebrates Surge in Revenue Despite Shortfall Per Share

Rapid Micro Biosystems Inc (RPID) Announces Surge in Revenue, but Faces Shortfall Per Share
In its latest financial report released on June 30, 2023, Rapid Micro Biosystems Inc (RPID) revealed a remarkable increase in revenue by 29.585% to $5.00 million compared to the corresponding period last year. However, this growth came with a drawback as the company experienced a shortfall per share of $-0.33.
Despite facing a shortfall, RPID has stood strong amidst a challenging Labratory Analytical Instruments sector. While most of its peers in the industry witnessed a contraction in their top-line, RPID managed to achieve an impressive surge in revenue. In comparison to the previous period, RPID saw a slight growth in the shortfall from $-0.32 per share, and a decrease of -0.655% in revenue from $5.04 million.
During the second quarter of the fiscal year 2023, Rapid Micro Biosystems Inc reported a net shortfall of $-0.006 million, which demonstrates a significant improvement compared to the deficit of $-13.090 million in the same period a year ago. Excluding a $0.01 million tax charge, the results for the second quarter of 2023 would display a net profit for the company.
Analyzing the company's inventories, which can serve as an indicator of future demand, it was observed that inventories declined to $20.9 million at RPID compared to the previous quarter and the same period a year ago. This decline might suggest a decrease in demand for the company's products. Moreover, the level of accounts receivable also dropped to $20.9 million, leading some analysts to believe that a slowdown in demand may be the cause.

Rapid Micro Biosystems Inc

Rapid Micro Biosystems Inc Faces $0.01 Million Tax Charge: Potential Impact on Company's Finances

Rapid Micro Biosystems Inc, a biotechnology and pharmaceutical company, has reported a Return on Equity (ROE) of 8.98% in the first quarter of 2023, which is an all-time high for the company. While the net income of the company has been decreasing, it has been successful in improving its ROE when compared to the fourth quarter of 2022.
However, it should be noted that amidst the biotechnology and pharmaceutical industry, Rapid Micro Biosystems Inc has been outranked by 15 other companies that have a higher return on equity. Although the overall ranking of the company's ROE has improved in the first quarter of 2023, moving from 1898 to 1693, it is still important to consider the competition within the industry.


Rapid Micro Biosystems Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com